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Purpose: Two Chinese families (XT and YT) with congenital fibrosis of the extraocular muscles (CFEOM) were
identified. The purpose of this study was to determine if previously described Homo sapiens kinesin family member 21A
(KIF21A) mutations were responsible for CFEOM in these two Chinese pedigrees.
Methods: Clinical characterization and genetic studies were performed. Microsatellite genotyping for linkage to the
CFEOM1 and CFEOM3 loci was performed. The probands were screened for KIF21A mutations by bidirectional direct
sequencing. Once a mutation was detected in the proband, all other participating family members and 100 unrelated control
normal individuals were screened for the mutation.
Results: All affected individuals in family XT shared the common manifestations of CFEOM1. Family YT had two
affected individuals, a mother and a daughter. The daughter had CFEOM1, while her mother never had congential ptosis
but did have limited extraocular movements status post strabismus surgery. Haplotype analysis revealed that pedigree XT
was linked to the 12q CFEOM1 locus and the affected memberes harbored the second most common missense mutation
in KIF21A (2,861G>A, R954Q). Family YT harbored the most common missense de novo mutation in KIF21A (2,860C>T,
R954W). Both of these mutations have been previously described.
Conclusions: The observation of these two KIF21A mutations in a Chinese pedigree underscores the homogeneity of
these mutations as a cause of CFEOM1 and CFEOM3 across ethnic divisions.
Congenital fibrosis of the extraocular muscles (CFEOM)
is a hereditary ocular motility disorder characterized by non-
progressive restrictive ophthalmoplegia and ptosis [1].Three
inherited  forms  have  been  described:  CFEOM  Type  1
(CFEOM1; OMIM 135700) and CFEOM3 (OMIM 600638,
607034)  are  autosomal  dominant;  CFEOM2  (OMIM
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602078) is autosomal recessive. Three genetic loci (fibrosis
and 3 disease-causing genes (Homo sapiens kinesin family
member 21A [KIF21A], paired-like homeobox 2a, [ARIX or
PHOX2A], and tubulin beta 3, [TUBB3]) have been identified.
The  most  common  form  of  CFEOM  is  CFEOM1
(“classic”  CFEOM).  Individuals  have  bilateral
ophthalmoplegia and ptosis from birth. The primary vertical
position  of  each  eye  is  infraducted  at  least  10°  with  the
inability to raise either eye above the horizontal midline and
affected individuals demonstrate a characteristic “chin up”
head position. Horizontal movement is also impaired, but the
degree of residual horizontal movement can vary between
affected individuals. Individuals frequently have amblyopia
in at least one eye. CFEOM1 is inherited as a fully penetrant
autosomal dominant trait and maps to the CFEOM1 locus on
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of the extraocular muscles 1 [FEOM1], FEOM2, and FEOM3)chromosome  12cen  [2-5].  The  disease-causing  gene,
KIF21A, belongs to a family of kinesin motor proteins. The
most  common  KIF21A  mutations  alter  one  of  several
conserved amino acid residues within the KIF21A stalk region
that are thought to interfere with KIF21A dimerization [6].
Post-mortem pathologic studies have shown that CFEOM1 is
caused primarily by the absence or maldevelopment of the
superior  division  of  the  oculomotor  nerve  or  the
corresponding subnuclei [7].
TABLE 1. PRIMERS FOR MICROSATELLITE MARKERS.




ATA29H01 D12S1048 GGTCTGCTTAGGTCCCTTTT 55 209-229
    AAGGAACCAAGGAGTGGAAG    
Mfd75A D12S59 CTCACTCATGCTTGTTTTGA 60.3 164-179
    GATCACGTCAGACTGGGCT    
AFM092wd11 D12S331 TAACATTTATTCATCTCCATACTGA 57.8 175-181
    ACATGTAAGAGAGNAAGTTTACAAA    
AFM296yg5 D12S345 CAGCCTGGGTAACAAA 57.8 209-238
    AGCAATGTGTGCATTC    
UT8102 D16S689 GCCTGGGCGATAAGTGAGA 56 209
    TCACCACAACCCAAACATTC    
AFM156xb8 D16S3026 CTCCCTGAGCAACAAACACC 55 178-210
    GGTCATTTATATGCGCCTGA    
AFMa306yf1 D16S3063 AGCTTGTTTTAGCAANAATTTC 59 218-260
    TGCCTGATTCCACCAA    
AFM342xd9 D16S3121 CATGTTGTACATCGTGATGC 58 79-85
    AGCTTTTATTTCCCAGGGGT    
TABLE 2. KIF21A PCR PRIMERS.
Exon Primer sequences (5’>3’) Product size (bp) Annealing temperature (°C)
21 F:GGGGGTTTGATGGTACTGTAT 354 54
  R:CTTCATGTAAAAACTGAAAGTGCT    
20 F:AAATGGCTCATTATTTGGCA 304 52
  R:CAGGGAACAAAATTGGAAGA    
8 F:TTTTAGCATTTTAGGTGCTTTT 306 52
  R:AAAGTGCCAGCCTTAGATGT    
          Note: F:forward primers; R:reverse primers
Figure 1. Photographs of individual II:4 in pedigree XT. Photos are taken in primary gaze (E) and in the 8 cardinal gaze positions (A, B, C,
D, F, G, H, and I). This subject demonstrates marked ophthalmoparesis, infraducted eyes in primary position, exotropia, and an inability to
raise the eyes above midline. This patient also has bilateral ptosis (not shown).
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2063Individuals with the recessive disorder CFEOM2 were
found in consanguineous pedigrees, mapped to the CFEOM2
locus on 11q13 [8] and result from homozygous mutations in
ARIX  (PHOX2A)  [9,10].  ARIX  encodes  a  homeodomain
transcription  factor  essential  to  the  development  of  the
oculomotor and trochlear motoneurons in mice and zebrafish
[11,12]. The CFEOM2 phenotype is characterized by bilateral
exotropia, ophthalmoplegia, and ptosis from birth.
CFEOM3 is much less common than CFEOM1 and is
inherited  as  an  autosomal  dominant  trait  with  variable
penetrance and variable expressivity. By definition, CFEOM3
families contain at least one affected member with unilateral
disease, no ptosis, eyes that are not infraducted in primary eye
position, or the ability to raise at least one eye above the
horizontal midline [13]. Most families with CFEOM3 map to
16qter [14-16] and harbor TUBB3 mutations [17], but some
families  map  to  the  CFEOM1  locus  and  harbor  KIF21A
mutations [13-16].
We clinically characterized two Chinese families with
autosomal  dominant  CFEOM.  To  determine  if  these  two
families were linked to the CFEOM1 or CFEOM3 loci, we
performed  linkage  analysis.  We  then  performed  mutation
screening of three coding exons of KIF21A (exon 8, 20, and
21) that contain the previously described KIF21A mutations.
METHODS
Clinical  studies:  Ophthalmologic  examinations  were
performed  and  blood  samples  were  obtained  from  all
participants after obtaining informed consent. Investigations
were conducted according to the guidelines of the Declaration
of Helsinki. The study was approved by and performed at the
Affiliated Hospital of Medical College Qingdao University,
Qingdao Municipal Science and Technology Commission.
The primary position of gaze, ductions, and versions with
cover  test  were  analyzed  and  quantified  in  6  diagnostic
positions.  Affected  individuals  underwent  forced  duction
testing.  Globe  retraction  and/or  aberrant  movements  were
observed. The width of the palperbral fissure was measured.
Levator function was measured from the upper lid margin
while  the  individual  attempted  supraduction  from  the
infraducted position without recruiting the frontalis muscle.
Ptosis was defined if the upper lid covered 2 mm or more of
the iris. Ptosis was graded as mild if the upper lid covered the
iris above the upper papillary margin, moderate if it occluded
up to half the pupil, and severe if it occluded more than half
of the pupil [18]. Visual acuity and non-cycloplegic refraction
were  obtained  when  possible.  All  of  the  ophthalmologic
examinations were recorder with a digital camera.
Molecular genetic studies:
Figure  2.  Clinical  features  of  three
individuals from two Chinese pedigrees
with  CFEOM.  The  second  and  third
columns  document  the  range  of
extraocular movement in each eye and
the  position  of  the  eyes  in  primary
position. Extraocular movement is rated
on a scale of 0 to 4, with 0 indicating no
movement  in  that  direction  and  4
indicating  normal  movement  in  that
direction. The black dot indicates the
position of the pupil within the orbit in
primary  gaze.  SR=superior  rectus;
IR=inferior  rectus;  LR=lateral  rectus;
MR=medial  rectus;  SO=superior
oblique;  IO=inferior  oblique.  The
presence  of  ptosis,  aberrant  eye
movements, forced duction testing, and
“chin-up” head position is also noted.
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2064Genotyping—Blood  samples  were  obtained  from  all
participating  family  members.  Lymphocyte  DNA  was
extracted  using  the  Puregene  kit  (Waston’s  biotechnique
company, Shanghai, China). Linkage studies were conducted
using the following polymorphic DNA microsatellite markers
from the FEOM1 and FEOM3 regions: D12S345, D12S59,
D12S331, and D12S1048 were analyzed to assess linkage to
the  dominant  CFEOM1region;  D16S3063,  D16S689,
D16S3026, and D16S3121 were analyzed to assess linkage to
the dominant CFEOM3 region. The primer sequences are
available from the Genome Data Base (Table 1). Primers were
purchased  from  Biotechnologies  Incorporation  (Shanghai,
China). Amplification was performed as reported elsewhere
using standard techniques [3,14]. Briefly, each polymorphic
DNA microsatellite marker was amplified for 35 cycles of 40
s at 94 °C for 75 s at the annealing temp as indicated in Table
1 for a given primer set, 20 s at 72 °C and followed by 7 min
at  72  °C.  The  polymerase  chain  reaction  products  were
separated  on  6%  denaturing  polyacrylamide  gels,  and  the
alleles were visualized by silver staining.
Lod scores were calculated for the family XT using the
Linkage version 5.2 package of programs with the assumption
of autosomal dominant inheritance with complete penetrance,
a disease incidence of 1 in 1 million births, and 10 marker
Figure 3. Motility photographs of individual II:1 from pedigree YT. Photos are taken in primary gaze (E) and in the 8 cardinal gaze positions
(A, B, C, D, F, G, H, I). This individual had strabismus surgery at age 18 years and does not demonstrate all of the typical features of CFEOM.
Although her upgaze is restricted, her eyes are not infraducted in primary position and she has no ptosis. Downgaze and horizontal eye
movements are relatively well preserved. Her parents are clinically unaffected and her daughter has typical features of CFEOM1 (Figure 2).
This individual has a de novo KIF21A mutation.
Figure 4. Motility photographs of individual III:1 in pedigree YT. Photos are taken in primary gaze (E) and in the 8 cardinal gaze positions
(A, B, C, D, F, G, H, I). This individual has typical CFEOM1 features, including infraduction of the eyes in primary position, inability to
elevate the eyes of midline, and ptosis (not shown).
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2065alleles of equal frequency, as previously described [4,18].
Haplotype analysis was examined in family YT to determine
segregation of the potentially affected allele among family
members.
KIF21A mutation detection—Mutation detection was
conducted by PCR amplification of exons 8, 20, and 21 of the
KIF21A  gene  and  flanking  intron-exon  boundaries  from
genomic DNA of each proband in the two families. The PCR
sequencing primers and conditions were listed in Table 2.
Briefly, the procedure of PCR was as follows: Cycle 1: initial
denaturation at 95 °C for 15 min. Cycle 2-15: touchdown
PCR: denature at 94 °C × 40 s, anneal × 60 s (start annealing
at 7 °C above the annealing temp as indicated in Table 2 for
a given primer set and decrease in increments of 0.5 °C /cycle
for a total of 14 cycles), elongate at 72 °C for 60 s. Cycles
16-35: 94 °C for 40 s, annealing temp as indicated in Table 2
for a given primer set for 60 s, 72 °C for 60 s. Cycle 36: final
extension  at  72  °C  for  10  min  [6].  The  amplicons  were
subjected to bidirectional direct DNA sequencing on an ABI
3730 DNA sequencer (Applied Biosystems Inc., Carlsbad,
CA).  To  further  establish  the  pathogenicity  of  mutations
detected in the probands, all participating family members and
100 unrelated, normal Chinese individuals were screened for
the mutation by direct sequencing.
RESULTS
Clinical findings: Family XT is from He Bei Province, China.
All affected members shared the typical clinical features of
CFEOM1 that have been reported previously in other ethnic
families: congenital non-progressive ptosis, infraducted globe
position in primary gaze, and upgaze and horizontal gaze
palsy in both eyes. All patients including the proband, had
evidence of aberrant innervation with nystagmoid movements
in all directions of gaze. Forced duction testing of the superior
rectus muscles and medial rectus muscles was positive (Figure
1  and  Figure  2).  Bell  phenomenon  was  absent.
Clinicopathological  studies  showed  fibrotic  extraocular
muscles in the proband.
Family YT is from Shandong Province, China. Individual
II:1 is the only subject in this study without congenital ptosis.
She had undergone bilateral inferior rectus recessions and
superior rectus resections at age 18 years. Her eyes can elevate
to the midline and the right eye is in neutral position in primary
gaze post operatively (Figure 2 and Figure 3). Individual III:
1  demonstrated  the  typical  features  of  CFEOM1:  non-
progressive ptosis, infraducted globe position in primary gaze,
and upgaze palsy (Figure 2 and Figure 4). At 3 years of age,
she  had  undergone  bilateral  ptosis  and  squint  surgery.
Preoperative forced duction tests confirmed tight inferior recti
and medial recti. Clinicopathological studies showed fibrotic
extraocular muscles in the proband. Bell phenomenon was
absent.
Molecular  genetics:  Genetic  analysis  revealed  probable
linkage  of  the  CFEOM1  phenotype  in  family  XT  to  the
KIF21A locus with a maximum lod score of 2.24 at D12S331
(theta=0, 100% penetrance). Linkage to the FEOM3 locus was
ruled-out  (Table  3,  Figure  5).  A  missense  heterozygous
mutation in KIF21A was identified in this family: 2,861G>A
(R954Q; Figure 6A,B). This mutation was detected in all
affected  and  no  affected  family  members  and  not  in  100
control subjects.
Linkage could not be established in Family YT because
only two individuals were affected. However, haplotype data
were  used  to  determine  co-inheritance  of  the  CFEOM
phenotype  with  the  FEOM1  and  FEOM3  loci  (Figure  7).
Sequence analysis of three coding exons in KIF21A revealed
a  missense  de  novo  heterozygous  mutation  (2,860C>T,
R954W) in affected individuals II:1 and III:1 (Figure 6C,D).
The remaining family members did not harbor the mutation,
including I:1. Thus, the mutation arose de novo in II:1 on the
allele she inherited from her father. Others have also reported
the occurance of de novo KIF21A mutations on the paternal
allele [13].
DISCUSSION
Recent studies suggest that the ptosis and primary defect in
vertical gaze found in CFEOM1 patients result from aberrant
TABLE 3. LOD SCORES FOR THE CHINESE PEDIGREE XT WITH CFEOM.
Recombination fraction (θ)
Marker 0.00 0.01 0.05 0.10 0.20 0.30 0.40 Zmax θmax
Family XT, 100% penetrance:
D12S345 1.49 1.45 1.31 1.13 0.73 0.34 0.05 1.49 0.00
D12S59 0.54 0.52 0.47 0.40 0.27 0.14 0.04 0.54 0.00
D12S331 2.24 2.20 2.02 1.79 1.28 0.75 0.26 2.24 0.00
D12S1048 2.04 2.00 1.84 1.63 1.18 0.71 0.28 2.04 0.00
D16S3063 -∞ -2.39 -1.05 -0.53 -0.12 0.02 0.04 0.04 0.40
D16S689 -∞ -3.12 -1.15 -0.41 0.14 0.27 0.21 0.27 0.30
D16S3026 -∞ -1.90 -0.61 -0.15 0.14 0.17 0.09 0.17 0.30
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2066development of the superior division of the oculomotor nerve
(cranial nerve III) or its subnuclei [7,19]. Autopsy studies of
an individual with CFEOM1 demonstrated a decrease in the
number of alpha motoneurons in all oculomotor subnuclei as
well as in the abducens nucleus. This finding suggests that the
KIF21A gene product may play a more generalized role in the
development of all of the ocular motor nuclei (cranial nerves
III, IV, and VI). Thus, KIF21A may be essential for the normal
development and/or axonal projection of a subset of human
alpha motoneurons in the brainstem. Studies to date have
provided strong evidence that the CFEOM1 phenotype results
from mutations in KIF21A and that sporadic cases are due to
de novo mutations in the same gene [20,21].
KIF21A, at the FEOM1 locus spans ~150 kb of genomic
DNA has an open reading frame of 5,022 bp and consists of
38 exons with alternative splicing of exon 12 and exons 29–
31  [6].  This  gene  is  predicted  to  encode  a  kinesin  motor
protein, KIF21A, which is responsible for the transport of
membranous organelles, protein complexes, and mRNAs to
specific destinations within the cell in a microtubule- and
ATP-dependent  manner.  These  functions  are  essential  for
normal morphogenesis and functioning of the cell [22].
Mutational analysis of KIF21A in 70 CFEOM1 probands
revealed a total of 12 different missense mutations [6,9,21,
23-25]. Of these mutations, mutation 1067T>C (M356T) was
observed in exon8, mutations 2,830G>C (E944Q), 2,839A>G
(M947V), 2,840T>C(M947T) and 2,840T>G (M947R) were
observed  in  exon  20,  and  mutations  2,860C>T  (R954W),
2,861G>A  (R954Q),  2,861G>T  (R954L),  3,022G>C
(A1008P) and 3,029T>C (I1010T) were observed in exon 21,
mutation  84C>G  (C28W)were  observed  in  exon  2.  The
2,860C>T (70%) and 2,861G>A (11%) mutations were the
most commonly identified mutations in the populations of
Caucasian,  Hispanic,  Turkish,  Iranian,  African,  Saudi
Arabian,  French,  Canadian,  Australian,  Swiss,  German,
Venezuelan, Italian, Chilian, Indian, English, and Taiwanese
[21].  The  most  commonly  identified  KIF21A  mutation,
2,860C>T  (R954W)  has  subsequently  been  observed  in
families from China [26]. Ali et al. [27] demonstrated that all
the CpG dinucleotides in exon 21, including the dinucleotides
that  harbor  the  two  most  frequently  encountered  KIF21A
Figure  5.  Pedigree  and  haplotype
analysis of family XT at the FEOM1 and
FEOM3  loci.  Black  symbols  identify
clinically  affected  individuals.
Genotyping  data  and  schematic
haplotype bars for FEOM1 markers (A)
and  FEOM3  markers  (B)  are  shown
below the symbol for each individual.
The  black  bars  denote  the  potential
disease-associated  alleles.  The  white
bars  indicate  the  inheritance  of  non
disease-associated haplotypes.
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2067mutations, were methylated in genomic DNA from blood and
sperm cells. The authors proposed that methylation of certain
CpG dinucleotides in KIF21A makes them more susceptible
to disease-causing mutations at specific genetic locations.
The diagnosis of CFEOM1 in family XT was based upon
the observation of autosomal dominant inheritance, bilateral
congenital  ptosis,  bilateral  infraducted  globe  position  in
primary gaze, and severely restricted upgaze. Genetic analysis
demonstrated that the phenotype was linked to the FEOM1
locus. A missense heterozygous mutation 2,861G>A (R954Q)
was identified in this family. This mutation is the second most
commonly observed KIF21A mutation in previously reported
pedigrees and sporadic cases.
Based on the clinical examination and photographs at
different  ages,  affected  member  III:1  of  pedigree  YT  has
typical CFEOM1 features with congenital  non-progressive
bilateral ptosis, downward eye position, inability to elevate
the  eyes  above  the  horizontal  midline,  and  aberrant  eye
movements. In contrast, affected member II:1 does not have
ptosis or aberrant eye movements; the absence of ptosis results
in a diagnosis of CFEOM3 rather than CFEOM1. Sequencing
revealed  that  the  two  affected  individuals  in  this  family
harbored the most commonly observed KIF21A mutation,
2,860C>T (R954W), that arose de novo on the paternal allele
of  II:1.  There  are  previous  reports  of  KIF21A  mutations
associated with the CFEOM3 phenotype, as well as of de novo
KIF21A  mutations,  which  typically  occur  on  the  paternal
Figure 6. Sequence chromatographs of
Family XT (A, B) and YT (C, D). The
sequence of the unaffected member is
normal (A, C), the affected patient with
CFEOM  harbor  the  heterozygous
KIF21A  mutation  2861G>A  (B)  and
2860C>T (D), respectively.
Figure  7.  Pedigree  and  haplotype
analysis of Family YT at the FEOM1
and  FEOM3  loci.  Black  symbols
identify clinically affected individuals.
Genotyping  data  and  schematic
haplotype bars for FEOM1 markers (A)
and  FEOM3  markers  (B)  are  shown
below the symbol for each individual.
The  black  bars  denote  the  potential
disease-associated  alleles.  The  white
bars  indicate  the  inheritance  of  non
disease-associated haplotypes.
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2068allele [13]. The KIF21A 2,860C>T mutation has also been
reported in a Taiwanese pedigree [23] and a Chinese family
with CFEOM3 [26].
These  pedigrees  support  the  previous  reports  of  both
inherited and de novo hot-spot KIF21A mutations underlying
the CFEOM1 and, rarely, the CFEOM3 phenotype.
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